Contemporary Clinical Trials 66 (2018) 45–50 Contents lists available at ScienceDirect Contemporary Clinical Trials journal homepage: www.elsevier.com/locate/conclintrial Evaluation of the sST2-guided optimization of medical treatments of patients admitted for heart failure, to prevent readmission: Study protocol for a randomized controlled trial a, a b c,d,e,f b Corentin Curinier , Kamila Solecki , Anne-Marie Dupuy , Cyril Breuker , Manuela Lotierzo , d a a a a Laetitia Zerkowski , Eran Kalmanovich , Mariama Akodad , Jérôme Adda , Pascal Battistella , c b a,b,c,d,e,f a a Audrey Castet-Nicolas , Nils Kuster , Sandra Marques , Sonia Soltani , Marine Chettouh , c c d,f d,f e Anne Verchere , Claire Belloc , Camille Roubille , Pierre Fesler , Grégoire Mercier , b,f c a,f Jean-Paul Cristol , Yohan Audurier , François Roubille Cardiology Department, University Hospital of Montpellier, Montpellier, France Department of Biochemistry, Centre Ressources Biologiques de Montpellier, University Hospital of Montpellier, Montpellier, France Pharmacy Department, University Hospital of Montpellier, Montpellier, France Internal Medicine and Hypertension Department, Lapeyronie Hospital, Montpellier University, Montpellier, France Economic evaluation unit at Montpellier teaching hospital, University of Montpellier, Montpellier, France PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, 34295 Montpellier, Cedex 5, France
Contemporary Clinical Trials – Elsevier
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera